Skip to main content
SpringerLink
Log in

Atezolizumab/bevacizumab

Immune-related myositis and immune-related adverse event-induced myocarditis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Iwasaki S, et al. A case of immune checkpoint inhibitor-associated myocarditis after initiation of atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma. Clinical Journal of Gastroenterology 14: 1233-1239, No. 4, Aug 2021. Available from: URL: http://doi.org/10.1007/s12328-021-01442-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Atezolizumab/bevacizumab. Reactions Weekly 1874, 46 (2021). https://doi.org/10.1007/s40278-021-02703-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-02703-2

Search

Navigation